66 related articles for article (PubMed ID: 12397077)
1. Mucin core O-glycosylation is modulated by neighboring residue glycosylation status. Kinetic modeling of the site-specific glycosylation of the apo-porcine submaxillary mucin tandem repeat by UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases T1 and T2.
Gerken TA; Zhang J; Levine J; Elhammer A
J Biol Chem; 2002 Dec; 277(51):49850-62. PubMed ID: 12397077
[TBL] [Abstract][Full Text] [Related]
2. Ser and Thr acceptor preferences of the GalNAc-Ts vary among isoenzymes to modulate mucin-type O-glycosylation.
Daniel EJP; Las Rivas M; Lira-Navarrete E; García-García A; Hurtado-Guerrero R; Clausen H; Gerken TA
Glycobiology; 2020 Oct; 30(11):910-922. PubMed ID: 32304323
[TBL] [Abstract][Full Text] [Related]
3. Polypeptide N-acetylgalactosaminyltransferase (GalNAc-T) isozyme surface charge governs charge substrate preferences to modulate mucin type O-glycosylation.
Ballard CJ; Paserba MR; Paul Daniel EJ; Hurtado-Guerrero R; Gerken TA
Glycobiology; 2023 Oct; 33(10):817-836. PubMed ID: 37555669
[TBL] [Abstract][Full Text] [Related]
4. Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family.
Bennett EP; Mandel U; Clausen H; Gerken TA; Fritz TA; Tabak LA
Glycobiology; 2012 Jun; 22(6):736-56. PubMed ID: 22183981
[TBL] [Abstract][Full Text] [Related]
5. The beginnings of mucin biosynthesis: the crystal structure of UDP-GalNAc:polypeptide alpha-N-acetylgalactosaminyltransferase-T1.
Fritz TA; Hurley JH; Trinh LB; Shiloach J; Tabak LA
Proc Natl Acad Sci U S A; 2004 Oct; 101(43):15307-12. PubMed ID: 15486088
[TBL] [Abstract][Full Text] [Related]
6. An unusual dual sugar-binding lectin domain controls the substrate specificity of a mucin-type O-glycosyltransferase.
Collette AM; Hassan SA; Schmidt SI; Lara AJ; Yang W; Samara NL
Sci Adv; 2024 Mar; 10(9):eadj8829. PubMed ID: 38416819
[TBL] [Abstract][Full Text] [Related]
7. The GalNAc-T Activation Pathway (GALA) is not a general mechanism for regulating mucin-type O-glycosylation.
Herbomel GG; Rojas RE; Tran DT; Ajinkya M; Beck L; Tabak LA
PLoS One; 2017; 12(7):e0179241. PubMed ID: 28719662
[TBL] [Abstract][Full Text] [Related]
8. The structure of the colorectal cancer-associated enzyme GalNAc-T12 reveals how nonconserved residues dictate its function.
Fernandez AJ; Daniel EJP; Mahajan SP; Gray JJ; Gerken TA; Tabak LA; Samara NL
Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20404-20410. PubMed ID: 31548401
[TBL] [Abstract][Full Text] [Related]
9. ISOGlyP: O-Glycosylation Site Prediction Using Peptide Sequences and GALNTs.
Mazuca LG; Mohl JE
Methods Mol Biol; 2024; 2763():237-247. PubMed ID: 38347415
[TBL] [Abstract][Full Text] [Related]
10. Targeting host O-linked glycan biosynthesis affects Ebola virus replication efficiency and reveals differential GalNAc-T acceptor site preferences on the Ebola virus glycoprotein.
Bagdonaite I; Abdurahman S; Mirandola M; Pasqual D; Frank M; Narimatsu Y; Joshi HJ; Vakhrushev SY; Salata C; Mirazimi A; Wandall HH
J Virol; 2024 May; ():e0052424. PubMed ID: 38757972
[TBL] [Abstract][Full Text] [Related]
11. Emerging Roles of UDP-GalNAc Polypeptide N-Acetylgalactosaminyltransferases in Cardiovascular Disease.
Guo L; Zhou L; Wei P; Li S; He S; Li D
Aging Dis; 2024 Mar; ():. PubMed ID: 38502587
[TBL] [Abstract][Full Text] [Related]
12. TAILS N-terminomics and proteomics reveal complex regulation of proteolytic cleavage by
King SL; Goth CK; Eckhard U; Joshi HJ; Haue AD; Vakhrushev SY; Schjoldager KT; Overall CM; Wandall HH
J Biol Chem; 2018 May; 293(20):7629-7644. PubMed ID: 29593093
[TBL] [Abstract][Full Text] [Related]
13. Bump-and-hole engineering of human polypeptide N-acetylgalactosamine transferases to dissect their protein substrates and glycosylation sites in cells.
Calle B; Gonzalez-Rodriguez E; Mahoney KE; Cioce A; Bineva-Todd G; Tastan OY; Roustan C; Flynn H; Malaker SA; Schumann B
STAR Protoc; 2023 Mar; 4(1):101974. PubMed ID: 36633947
[TBL] [Abstract][Full Text] [Related]
14. Deficiency of polypeptide N-acetylgalactosamine transferase 9 contributes to a risk for Parkinson's disease via mitochondrial dysfunctions.
Peng Y; Wang C; Ma W; Chen Q; Xu G; Kong Y; Ma L; Ding W; Zhang W
Int J Biol Macromol; 2024 Apr; 263(Pt 2):130347. PubMed ID: 38401583
[TBL] [Abstract][Full Text] [Related]
15. Sequence-Specific Mucins for Glycocalyx Engineering.
Pan H; Colville MJ; Supekar NT; Azadi P; Paszek MJ
ACS Synth Biol; 2019 Oct; 8(10):2315-2326. PubMed ID: 31500407
[TBL] [Abstract][Full Text] [Related]
16. A novel role for GalNAc-T2 dependent glycosylation in energy homeostasis.
Verzijl CRC; Oldoni F; Loaiza N; Wolters JC; Rimbert A; Tian E; Yang W; Struik D; Smit M; Kloosterhuis NJ; Fernandez AJ; Samara NL; Ten Hagen KG; Dalal K; Chernish A; McCluggage P; Tabak LA; Jonker JW; Kuivenhoven JA
Mol Metab; 2022 Jun; 60():101472. PubMed ID: 35304331
[TBL] [Abstract][Full Text] [Related]
17. The antibiotic vancomycin induces complexation and aggregation of gastrointestinal and submaxillary mucins.
Dinu V; Lu Y; Weston N; Lithgo R; Coupe H; Channell G; Adams GG; Torcello Gómez A; Sabater C; Mackie A; Parmenter C; Fisk I; Phillips-Jones MK; Harding SE
Sci Rep; 2020 Jan; 10(1):960. PubMed ID: 31969624
[TBL] [Abstract][Full Text] [Related]
18. Enzymatic glycosylation of peptide arrays on gold surfaces.
Laurent N; Voglmeir J; Wright A; Blackburn J; Pham NT; Wong SC; Gaskell SJ; Flitsch SL
Chembiochem; 2008 Apr; 9(6):883-7. PubMed ID: 18330850
[No Abstract] [Full Text] [Related]
19. Galnt17 loss-of-function leads to developmental delay and abnormal coordination, activity, and social interactions with cerebellar vermis pathology.
Chen CY; Seward CH; Song Y; Inamdar M; Leddy AM; Zhang H; Yoo J; Kao WC; Pawlowski H; Stubbs LJ
Dev Biol; 2022 Oct; 490():155-171. PubMed ID: 36002036
[TBL] [Abstract][Full Text] [Related]
20. Rapid building block-economic synthesis of long, multi-
Galashov A; Kazakova E; Stieger CE; Hackenberger CPR; Seitz O
Chem Sci; 2024 Jan; 15(4):1297-1305. PubMed ID: 38274058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
